09.12.2009 • News

Arkema Q1 Sales €1.092 Billion

Arkema announced Q1 sales of €1.092 billion. Q1 Ebitda fell by 64 % to €57 million. Visibility remains very low, and the company cannot see any noticeable improvement in the economic ­environment. Arkema says it confirmed its target to generate a positive free cash flow in 2009 and also confirmed its target to reduce fixed costs by
€550 million in 2010 compared to 2005.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read